Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension

Journal of Human Hypertension volume 16, pages 399–404 (2002)Cite this article

Abstract

Increased urine albumin excretion is associated with an unfavourable cardiovascular risk profile and prognosis in primary hypertension, even though its pathogenesis is currently unknown. Microalbuminuria (Mi) has been proposed as an integrated marker to identify patients with subclinical organ damage, but its routine use is still too often neglected in clinical practice. The aim of our study was to evaluate the relationship between urinary albumin excretion and early signs of subclinical target organ damage (TOD), namely left ventricular hypertrophy and carotid atherosclerosis in a large group of non diabetic hypertensive patients. A group of 346 never treated patients with primary hypertension (212 men, 134 women, mean age 47 ± 9 years) referred to our clinic were included in the study. They underwent the following procedures: (1) family and personal medical history and physical examination; (2) clinical blood pressure measurement; (3) routine blood chemistry and urine analysis including determination of urinary albumin excretion (ACR); (4) electrocardiogram; (5) ultrasound evaluation of left ventricular mass (LVMI) and carotid artery thickness (IMT). The overall prevalence of Mi, left ventricular hypertrophy, and carotid plaque was 13, 51, and 24% respectively. Mi was significantly correlated with LVMI (P < 0.0001), IMT (P < 0.0001) and several metabolic and non-metabolic risk factors (blood pressure, body mass index, serum lipids). Cluster analysis identified three subgroups of patients who differ significantly with regards to TOD and albuminuria (P ⩽ 0.001 for each of the examined variables). Patients with higher IMT and LVMI values also showed increased ACR levels. Furthermore, patients with microalbuminuria were more likely to have both LVH and IMT values above the median for the study population (OR 21, C.I. 4.6–99.97, P < 0.0001). Mi is an integrated marker of subclinical organ damage in patients with primary hypertension. Evaluation of urinary albumin excretion is a specific, cost-effective way to identify patients at higher risk for whom additional preventive and therapeutic measures are advisable.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 1997; 157: 2413–2446

  2. Chalmers J et al. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization Clin Exp Hypertens 1999; 21: 1009–1060

    Article  CAS  Google Scholar 

  3. Pontremoli R . Microalbuminuria in essential hypertension – its relation to cardiovascular risk factors Nephrol Dial Transplant 1996; 11: 2113–2115

    Article  CAS  Google Scholar 

  4. Bianchi S, Bigazzi R, Campese VM . Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications Am J Kidney Dis 1999; 34: 973–995

    Article  CAS  Google Scholar 

  5. Borch-Johnsen K et al. Urinary albumin excretion. An independent predictor of ischemic heart disease Arterioscler Thromb Vasc Biol 1999; 19: 1992–1997

    Article  CAS  Google Scholar 

  6. Jensen JS et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease Hypertension 2000; 35: 898–903

    Article  CAS  Google Scholar 

  7. Viberti G, Thomas S . Should we screen for microalbuminuria in essential hypertension? Am J Kidney Dis 1999; 34: 1139–1141

    Article  CAS  Google Scholar 

  8. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 1972; 18: 499–502

    CAS  PubMed  Google Scholar 

  9. Cockcroft WD, Gault MH . Prediction of creatinine clearance from serum creatinine Nephron 1976; 16: 31–34

    Article  CAS  Google Scholar 

  10. Pontremoli R et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study Hypertension 1997; 30: 1135–1143

    Article  CAS  Google Scholar 

  11. Mangili R et al for the Italian Microalbuminuria Study Group. Prevalence of hypertension and microalbuminuria in adult type 1 (insulin dependent) diabeticpatients without renal failure in Italy. Validation of screening techniques to detect albuminuria Acta Diabetol 1992; 29: 156–166

    Article  Google Scholar 

  12. Sokolow M, Lyon TP . The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb reads Am Heart J 1949; 37: 161–186

    Article  CAS  Google Scholar 

  13. Casale PN et al. Improved sex-specific detection of left ventricular hypertrophy: development and prospective validation of improved criteria J Am Coll Card 1985; 6: 572–580

    Article  CAS  Google Scholar 

  14. Schiller NB et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms J Am Soc Echocardiogr 1989; 2: 358–367

    Article  CAS  Google Scholar 

  15. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 1986; 57: 450–458

    Article  CAS  Google Scholar 

  16. De Simone G et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk J Am Coll Cardiol 1995; 25: 1056–1062

    Article  CAS  Google Scholar 

  17. Savage DD et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham study Circulation 1987; 75 (Suppl I): I-26–1-33

    Google Scholar 

  18. Kawagishi T et al. High-resolution B-Mode ultrasonography in evaluation of atherosclerosis in uremia Kidney Intern 1995; 48: 820–826

    Article  CAS  Google Scholar 

  19. Weldelhag I, Wiklund O, Wikstrand J . Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: ultrasonographic assessment of intima-media thickness and plaque occurrence Arterioscler Thromb 1993; 13: 1404–1411

    Article  Google Scholar 

  20. Tryon RC, Bailey D . Cluster Analysis McGraw-Hill Book Co: New York 1970; pp 1–347

    Google Scholar 

  21. Pontremoli R et al. Left ventricular geometry and function inpatients with essential hypertension and microalbuminuria J Hypertens 1999; 17: 993–1000

    Article  CAS  Google Scholar 

  22. Bigazzi R et al. Increased Thickness of carotid artery inpatients with essential hypertension and microalbuminuria J Hum Hypertens 1995; 9: 827–833

    CAS  Google Scholar 

  23. Pedrinelli R . Microalbuminuria in essential hypertension Nephron 1996; 73: 499–505

    Article  CAS  Google Scholar 

  24. Pedrinelli R et al. Microalbuminuria and endothelial dysfunction in essential hypertension Lancet 1994; 344: 14–18

    Article  CAS  Google Scholar 

  25. Pontremoli R et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension Nephrol Dial Transplant 1995; 10 (Suppl 6): 6–9

    Article  Google Scholar 

  26. Campese VM, Bianchi S, Bigazzi R . Association between hyperlipidemia and microalbuminuria in essential hypertension Kidney Int 1999; 71: S10–S13

    Article  CAS  Google Scholar 

  27. Agewall S, Lindstedt G, Fagerberg B . Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) in clinically healthy 58-year-old men Atherosclerosis 2001; 157: 197–202

    Article  CAS  Google Scholar 

  28. Baldoncini R et al. High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensivepatients Kidney Int 1999; 56: 1499–1504

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grant no RF99.52 from Ministero della Sanità, Ricerca Finalizzata 1999. The excellent technical help of Cinzia Tomolillo, BS is gratefully acknowledged.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Nephrology, University of Genoa, Italy

    G Leoncini, M Ravera, F Viazzi, E Ratto, S Vettoretti, D Parodi, G Deferrari & R Pontremoli

  2. Department of Experimental Medicine, University of Genoa, Italy

    G Sacchi

  3. Department of Internal Medicine, Section of Cardiology, University of Genoa, Italy

    G P Bezante

  4. Department of Neurological Science and Neuro-rehabilitation, University of Genoa, Italy

    M Del Sette

Authors
  1. G Leoncini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Sacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Ravera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Viazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Ratto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Vettoretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Parodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G P Bezante
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Del Sette
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G Deferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R Pontremoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Pontremoli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leoncini, G., Sacchi, G., Ravera, M. et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens 16, 399–404 (2002). https://doi.org/10.1038/sj.jhh.1001408

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001408

Keywords

This article is cited by

Search

Advanced search

Quick links